
--- Page 1 ---
UUID:5E21E07E-BD5F-4AC7-985A-178416D756E2 TCGA-C8-A26Z-01A-PR Redacted IRB APPROVED Multt-media systems, Inc. Form Revised Clinical Case Report. Jcs-o-3 (For Collection of Cancerous Tissue) Carcnomo, mfilmatmy 8500/3 duct, Nos Site; busst, Nos c50.9 hws 5/24fn Informed Consent J SSun :I personally informed this patient that a specimen(s) would be collected to be used for research. purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Signature Date Name of Physician or Study Coordinator Clinical Information SNEAGENERALINFORMATONSSTS Date of Birth (mm/dd/yy) Height Marital Status Race. Temperature A Married 370 c  Single  Divorced  Widow  Blood Pressure Heart Rate Gender Weight 100/g0mmitj  Male Female HISTORYOFPRESENTILLNESS Chief Complaints: The siiyht brenit-I Symptoms: Dahet Clinical Findings: Iutbe bp He reylt Breort Axily m Performance Scale (Karnofsky Score):   60-70 Symptomatic, in bed less than 50% of day  100 Asymptomatic  80-90 Symptomatic but Fully Ambulatory  20-30 Bed Ridden  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden CURRENTMEDICATIONS Frequency Date (mm/dd/yyyy) Drug Dose Route 1 To / To To To To

--- Page 2 ---
:* +  7 PAST MEDICAL HISTORY Diagnosis/Disease/Disorder/Injury  Diagnosis Date Treatment Status Besur SOB/GYN HISTORY**. . Date of First Mensesd # of Pregnancies Menopausal Status  Pre-menopausal yearsrep Dat I ast Menses # of Live Births  Peri-Menopausal Post-menopausa! years rf Birth Control:  Condom  Oral Contrace...e  iUD  Hormone Replacement /A Therapy:  Other: RSOCIALHISTORWAR. .... Occupation: Environmental Hazards: Smoking History. Duration When Quit Current Status TYPE Packs/day (yrs) (yr)  yES NO Alcohol Consumption Drinks/day Duration When Quit Current Status TYPE (yrs) (yr) DYES tNO Drug Use Frequency Duration When Quit Current Status TYPE (yrs) (y  yes t NO HSFAMIEYMEDICALHISTORYS  Diagnosis Age of Diagnosis. Relative No br? Cauy LABDATA  Result Date Result Date Test Test CEA   Negative  Positive:  HIV  Negative  Positive: CA 15-3  Negative  Positive: Hep B  Negative  Positive: 7 CA 19-9  Negative  Positive:  Hep C  Negative  Positive: PSA  Negative  Positive: AFP   Negative  Positive: Other:  Negative  Positive: Other:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
DIAGNOSTIC STUDIES  Study  Results Date Ultrasound 1 N 54Ue X-Ray CT Endoscopy MRI Biopsy * CLINICAL DIAGNOSIS  .. Preoperative Clinical Diagnosis Rinlt brecf Location of Suspected Involved Lymph Nodes. Location of Suspected Distant Metastasis. Arllley NO IClinical Staging Date of Diagnosis Tg NI M o Stage: Treatment Information .AAPLKSURGICAL TREATMENTST Procedure Date of Procedure Phtey's swrgery. Primary Tumor Organ  Detailed Location Size Reeaet Leli 19.Sx x cm Extension of Tumor N Lymph Nodes Description Location of Lymph Nodes # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes. Axlla 13 Dissected Lymph Nodes Distant Metastasis  Organ Detailed Location Size M Surgical Staging T9. No. Mo Stage:L NEOADJUVENTHERAPY (Chemo Radiaton Immuno Hormonal orMolecular . Dose Route Frequency Date (mm/dd/yyy) Drug/Treatment To iVU To / To 1 1 To / / 1 1 To 3

--- Page 4 ---
Pathology Form Specimen Information Date: ime: Collected by: fime: Preserved by: . SPECIMENTYPE # of samplesovided) Stide  Paraffin Biock Blood/Serum/Plasma Frozen Diseased  Normal Diseased  Normal  Normal Diseased  Normal Diseased x x Time to LN2 ++a. Time to Formalin Time to LN2 for min  ts min min /1 . SR PATHOEOGICALDESCRIPTIONTS Primary Tumor Extension of Tumor  Distance to NAT Organ Size. N O 2 cm Rgreat cm Lymph Nodes # Metastasized # Examined Location 13 0 Axilg Distant Metastasis Size Detailed Location Organ Pathological Staging M 0 Stage: ICA . pT a No Notes:

--- Page 5 ---
COnSOLIdaTEd DIagnOsTIC pAthOLOgy fORm* Microscopic Appearance: Histological pattern: CELL DISTRIBUTION Diffuse + STRUCTURAL PATTERN Mosaic Streaning Necrosis  Storiform Lymphocytic Infiltration XFibrosis Vascular Invasion  Palisading Chusterized Cystic Degeneration Alveolar Formation Bleeding Indian File Myxoid Change Psanmoma/Caicification 2. Cellular features. Squamous +-Adenomatous Sarcomatous  Sguamoid Cell Glandular cel! Lymphomatous Round Cell Spindle Cell Cell Stratification Larre CeH Fibroblast Keratin Small Cell  Secretion X Osteoblast Desmosome  RS CeIVRS Like Intracyt. Vacuole Lipoblast Inflam. Cell Pear!  Gland formation Myoblast Plasma Cell Otherwise Specified: d71% sL7% 07712 2.Cellular Differentiation: Well Moderately Poor S Nuclear Atypia: Nuclear Appearaace  Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinncleated Giant Cell Mitotic Activity Nuckear Grade Histological Diagnosis: sh/tg/ms Ductal Caeefroq. Wos, G-s Comments: Director, Researctr Pathology PATHOLOGIST STAFF FOR RESEARCH USE OMLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND :